[1]
Barylski, M. 2024. A new era of thrombocardiology, that is the ?vascular? dose of rivaroxaban in the antithrombotic treatment of atherosclerotic diseases. Why, when and in whom?. Medycyna Faktow (J EBM). 17, 2(63) (Jun. 2024), 232-239. DOI:https://doi.org/10.24292/01.MF.0224.10.